The United Kingdom introduced the revised travel advisory for the country on Wednesday in which Covishield has qualified as an approved vaccine for travel in the country. The Covid-19 vaccine has been developed jointly by Oxford University and AstraZeneca and is currently being manufactured by the Serum Institute of India (SII). Travellers with a full dosage of Covishield will now be allowed to visit Great Britain from any part of the world from October 4 onwards.
The list also approves leading vaccines for Covid-19 such as Pfizer-BioNTech and Moderna from selected countries. Any traveller visiting the UK will be considered fully vaccinated if they have been injected with a full dose of the above-mentioned vaccines taken from recognised health bodies.
COVID19 | In its revised travel advisory, the UK government says Covishield qualifies as an approved vaccine pic.twitter.com/B5R52cDu6v
— ANI (@ANI) September 22, 2021